Navigation Links
Audacity, Inc. Welcomes Jill Collins, Ph.D.
Date:12/11/2013

San Diego, CA (PRWEB) December 11, 2013

San Diego based Audacity, Inc., a branding and advertising agency for health and life sciences, is proud to announce the addition of Jill Collins, PhD to its accounts team.

Dr. Collins joins Audacity as the agency’s new senior account guru, specifically in charge of account management and science. With a Ph.D. from University of Illinois at Chicago in medicinal chemistry and a BS degree in chemistry from University of Dayton, her extensive science background brings additional depth to the Audacity team.

“We are thrilled Jill is joining the Audacity team,” said Agency Chief and CEO, Gaëtan Fraikin. “She has a rare and extremely valuable breadth of expertise in both science and marketing that is really exciting. Her experience in the lab and her time in client-facing roles will allow her to connect with our customers on a more personal level.

“Jill’s skill set rounds out our highly capable team and her background enables her to hit the ground running for Audacity from day one.”

With five years working in the biotechnology industry, Collins’ credentials include recent work as the associate director of business development for GenWay Biotech, a biological reagents and biomarker diagnostic company and the director of marketing for Prognosys Biosciences, a next-gen sequencing company.

In addition to her scientific education and benchtop experience in pharmaceutical biotechnology, specifically protein crystallography, chemistry, and enzymology, Collins also has extensive knowledge in both marketing and business development. Her range of insights will allow the agency to intimately connect and relate to key issues companies in the life science and health industries face in growing their businesses.

“I’m thrilled to be joining this extremely talented and knowledgeable team,” says Collins. “Working closely with life science companies in order to translate their highly technical messages into successful branding is a very exciting prospect for me. In addition, I’m eager to help our clients spread their messages to their customers in a more creative manner.”

For more information on Collins, the Audacity team, or the services and solutions the agency offers, check out audacityhealth.com.

About Audacity:
Audacity builds health and science brand supremacy through disruptive branding and advertising. We combine strategy, art and technology in a range of transformative digital solutions. We simplify brands to the core. We push innovation to the edge and we connect brands — to drive revenue.

Press Contact:
Gaëtan Fraikin, Agency Chief/CEO, Audacity, Inc.
http://www.audacityhealth.com/
(858) 385-0664
pr(at)audacityheath(dot)com

Read the full story at http://www.prweb.com/releases/2013/12/prweb11407199.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. TaxOps Welcomes Stu Myhill as New Partner
2. Pursuit Welcomes Pankaj Gupta - VP, Analytics
3. Express Diagnostics Welcomes New Controller
4. City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall
5. WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data
6. DTx Inc. Welcomes New VP of Operations, Barbara Garofalo
7. Cepheid Welcomes Executive Vice President of Global Operations
8. Jackson Hole Group, LLC Welcomes Marnie McBryde as a New Principal
9. Amphora Research Systems welcomes Advanced Polymer Monitoring Technologies
10. CardioWise™ Welcomes Geoffrey Dalbow as Chief Technology Officer
11. ABC Welcomes New Advisory Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving ... those living in larger cities are affected by air pollution related diseases. , That ... countries globally - decided to take action. , “I knew I had to take ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
Breaking Biology Technology:
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
Breaking Biology News(10 mins):